China Medical Equipment Fair (CMEF) 2020, one of the most prestigious medical equipment shows, has lifted its curtain on Oct. 19, CST and come to a successful conclusion on Oct. 22, CST in Shanghai, China. Wondfo, as a leading company in China Point-of-care testing (POCT) industry, exhibited the full range of products and a new solution – POCT Lab, attracting lots of attention at the show.
Wondfo Thrombosis Test - more accurately & rapidly detect 6 coagulation indicators at a time
At CMEF, Wondfo exhibited the new product chemiluminescence immunoassay based Thrombosis Test, which had been launched in August at CACLP Expo. The product delivers lab results of 6 coagulation indicators - TAT, PIC, TM, t-PAIC, D-Dimer, FDP – in just a few minutes.
Extensive and Valuable Uses of Wondfo Thrombosis Test
- Diagnose the pre-DIC state of a patient so that medical professionals can provide early treatment, preventing from deteriorating to DIC.
- Classify types of DIC, which is important when choosing the treatment.
- Identify patients' risk of thrombosis, guiding the clinical decision making in the patient’s anticoagulation treatment.
- Evaluate the effect of thrombolytic therapy.
The product is ideal for orthopedics, Oncology, Cardiology, ICU, Obstetrics and Gynecology, Hematology, and other clinical departments that need the diagnosis and treatment of DIC and thrombosis, as well as the monitoring and evaluation of thrombolysis treatment.
New Solution Unveiled – POCT Lab, Creating A More Efficient ED
Wondfo’s new solution – POCT Lab, was unveiled at CMEF and became another highlight of the exhibition.